The Beating Heart of Solar Energy

The notion of using solar cells placed under the skin to continuously recharge implanted electronic medical devices is a viable one. Swiss researchers have done the math, and found that a 3.6 square centimeter solar cell is all that is needed to generate enough power during winter and summer to power a typical pacemaker. The study is the first to provide real-life data about the potential of using solar cells to power devices such as pacemakers and deep brain stimulators. According to lead author Lukas Bereuter of Bern University Hospital and the University of Bern in Switzerland, wearing power-generating solar cells under the skin will one day save patients the discomfort of having to continuously undergo procedures to change the batteries of such life-saving devices. The findings are set out in Springer's journal Annals of Biomedical Engineering.

Most electronic implants are currently battery powered, and their size is governed by the battery volume required for an extended lifespan. When the power in such batteries runs out, these must either be recharged or changed. In most cases this means that patients have to undergo implant replacement procedures, which is not only costly and stressful but also holds the risk of medical complications. Having to use primary batteries also influences the size of a device.

Various research groups have recently put forward prototypes of small electronic solar cells that can be carried under the skin and can be used to recharge medical devices. The solar cells convert the light from the sun that penetrates the skin surface into energy.

To investigate the real-life feasibility of such rechargeable energy generators, Bereuter and his colleagues developed specially designed solar measurement devices that can measure the output power being generated. The cells were only 3.6 square centimeters in size, making them small enough to be implanted if needed. For the test, each of the ten devices was covered by optical filters to simulate how properties of the skin would influence how well the sun penetrates the skin. These were worn on the arm of 32 volunteers in Switzerland for one week during summer, autumn and winter.

No matter what season, the tiny cells were always found to generate much more than the 5 to 10 microwatts of power that a typical cardiac pacemaker uses. The participant with the lowest power output still obtained 12 microwatts on average.

"The overall mean power obtained is enough to completely power for example a pacemaker or at least extend the lifespan of any other active implant," notes Bereuter. "By using energy-harvesting devices such as solar cells to power an implant, device replacements may be avoided and the device size may be reduced dramatically."

Bereuter believes that the results of this study can be scaled up and applied to any other mobile, solar powered application on humans. Aspects such as the catchment area of a solar cell, its efficiency and the thickness of a patient's skin must be considered.

Bereuter, L., Williner, S., Pianezzi, F. et al.
Energy Harvesting by Subcutaneous Solar Cells: A Long-Term Study on Achievable Energy Output.
Ann Biomed Eng (2017), doi: 10.1007/s10439-016-1774-4

Most Popular Now

ChatGPT Extracts Data for Ischaemic Stro…

In an ischaemic stroke, an artery in the brain is blocked by blood clots and the brain cells can no longer be supplied with blood as a result. Doctors must...

Herefordshire and Worcestershire Health …

Herefordshire and Worcestershire Health and Care NHS Trust has successfully implemented Alcidion's Miya Precision platform to streamline bed management workflow across seven community hospitals in Worcestershire. The trust delivers community...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...

New Horizon Europe Funding Boosts Europe…

The European Commission has announced the launch of new Horizon Europe calls, with a substantial funding pool of over €112 million. These calls are aimed primarily at pioneering projects in...

Cleveland Clinic Study Finds AI can Deve…

Cleveland Clinic researchers developed an artficial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on...

New AI-Technology Estimates Brain Age Us…

As people age, their brains do, too. But if a brain ages prematurely, there is potential for age-related diseases such as mild-cognitive impairment, dementia, or Parkinson's disease. If "brain age...

With Huge Patient Dataset, AI Accurately…

Scientists have designed a new artificial intelligence (AI) model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease. The model...

Radboud University Medical Center and Ph…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Radboud University Medical Center have signed a hospital-wide, long-term strategic partnership that delivers the latest patient monitoring...

GPT-4, Google Gemini Fall Short in Breas…

Use of publicly available large language models (LLMs) resulted in changes in breast imaging reports classification that could have a negative effect on patient management, according to a new international...

ChatGPT fails at heart risk assessment

Despite ChatGPT's reported ability to pass medical exams, new research indicates it would be unwise to rely on it for some health assessments, such as whether a patient with chest...

Study Shows ChatGPT Failed when Challeng…

With artificial intelligence (AI) poised to become a fundamental part of clinical research and decision making, many still question the accuracy of ChatGPT, a sophisticated AI language model, to support...

Virtual Reality Shows Promise in Fightin…

A new study published in JMIR Mental Health sheds light on the promising role of virtual reality (VR) in treating major depressive disorder (MDD). Titled "Examining the Efficacy of Extended...